Thermo Fisher Scientific, Pfizer collaborate to expand accesss to next-generation sequencing-based cancer testing in more than 30 countries
Pfizer and Thermo Fisher Scientific have agreed to collaborate to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable. Access to local NGS testing can […]
